<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04745260</url>
  </required_header>
  <id_info>
    <org_study_id>2020040016</org_study_id>
    <nct_id>NCT04745260</nct_id>
  </id_info>
  <brief_title>Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair</brief_title>
  <official_title>A Randomized Controlled Trial of Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Analgesia and Anxiolysis During Pediatric Facial Laceration Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Texas at Austin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Texas at Austin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the effectiveness of a combination of intranasal&#xD;
      fentanyl and intranasal midazolam to intranasal midazolam alone for analgesia and anxiolysis&#xD;
      in patients presenting for facial laceration repair in the pediatric emergency department.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a single blind (blinded observer) randomized control trial to evaluate the&#xD;
      efficacy of the combination of intranasal fentanyl and intranasal midazolam compared to&#xD;
      intranasal midazolam alone for analgesia and anxiolysis during pediatric facial laceration&#xD;
      repair.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>A non-blinded researcher (physician) will determine the group to which the patient is assigned and order the medication(s) according to the assigned group. A separate blinded researcher (physician) will then perform the laceration repair, mYPAS, and post-procedure evaluations. The non-blinded researcher, nurse, parent, and patient will be advised not to disclose which medication(s) were administered to ensure blinding of the provider performing the laceration repair and assessment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Modified Yale Preoperative Anxiety Score (mYPAS)</measure>
    <time_frame>Pre-procedure</time_frame>
    <description>mYPAS score at time of positioning, to be completed by blinded researcher (provider) to assess anxiety level. Scores range from 22.5 to 100, with higher scores indicating greater anxiety.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Provider Satisfaction with Procedural Sedation (Visual Analog Score)</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>VAS (visual analog score) completed by blinded researcher (provider) to rate satisfaction with level of sedation and ease of procedure. The scale will range from 0 (unsatisfied) to 100 (very satisfied).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parent Satisfaction with Anxiolysis (Visual Analog Scale)</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>VAS (visual analog score) completed by parent to rate satisfaction with level of anxiolysis for procedure. The scale will range from 0 (unsatisfied) to 100 (very satisfied).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Treatment Failure</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>Failure of intervention to provide appropriate anxiolysis and need for IV sedation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Procedure</measure>
    <time_frame>Immediately after the procedure</time_frame>
    <description>Duration of procedure from positioning to last suture placement, to be recorded by blinded researcher (provider)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Facial Laceration</condition>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Intranasal Midazolam and Intranasal Fentanyl</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Study participants assigned to the combination (experimental) group will receive a weight-based dose of intranasal Fentanyl (50mcg/mL concentration at 2mcg/kg up to 100mcg) followed by intranasal Midazolam (5mg/mL concentration at 0.2mg/kg up to 10mg) using a mucosal atomizer device (1mL syringe with an attached atomizer).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intranasal Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study participants assigned to the control (active comparator) group will receive only intranasal Midazolam (5mg/mL concentration at 0.3mg/kg up to 10mg) using a mucosal atomizer device (1mL syringe with an attached atomizer).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal Fentanyl Spray and Intranasal Midazolam Spray</intervention_name>
    <description>Intranasal Fentanyl 2mcg/kg and Intranasal Midazolam 0.2mg/kg</description>
    <arm_group_label>Intranasal Midazolam and Intranasal Fentanyl</arm_group_label>
    <other_name>Versed</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intranasal Midazolam Spray</intervention_name>
    <description>Intranasal Midazolam 0.3mg/kg</description>
    <arm_group_label>Intranasal Midazolam</arm_group_label>
    <other_name>Versed</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Facial laceration requiring repair with sutures&#xD;
&#xD;
          -  English or Spanish-speaking parent/guardian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Lacerations requiring IV sedation or subspecialist involvement&#xD;
&#xD;
          -  Patient has other injuries requiring medical attention&#xD;
&#xD;
          -  Patient has vital sign instability, per physician discretion&#xD;
&#xD;
          -  Patient has autism spectrum disorder&#xD;
&#xD;
          -  Patient has allergies to either medication&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brittany J DiFabio, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas at Austin</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Brittany J DiFabio, MD</last_name>
    <phone>512-324-0093</phone>
    <email>brittany.difabio@ascension.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Matthew Wilkinson, MD</last_name>
    <phone>512-324-0093</phone>
    <email>mhwilkinson@ascension.org</email>
  </overall_contact_backup>
  <reference>
    <citation>Fein JA, Zempsky WT, Cravero JP; Committee on Pediatric Emergency Medicine and Section on Anesthesiology and Pain Medicine; American Academy of Pediatrics. Relief of pain and anxiety in pediatric patients in emergency medical systems. Pediatrics. 2012 Nov;130(5):e1391-405. doi: 10.1542/peds.2012-2536. Epub 2012 Oct 29.</citation>
    <PMID>23109683</PMID>
  </reference>
  <reference>
    <citation>Kennedy RM, Luhmann JD. The &quot;ouchless emergency department&quot;. Getting closer: advances in decreasing distress during painful procedures in the emergency department. Pediatr Clin North Am. 1999 Dec;46(6):1215-47, vii-viii. Review.</citation>
    <PMID>10629683</PMID>
  </reference>
  <reference>
    <citation>Miller JL, Capino AC, Thomas A, Couloures K, Johnson PN. Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair. J Pediatr Pharmacol Ther. 2018 Mar-Apr;23(2):72-83. doi: 10.5863/1551-6776-23.2.72. Review.</citation>
    <PMID>29720907</PMID>
  </reference>
  <reference>
    <citation>Ryan PM, Kienstra AJ, Cosgrove P, Vezzetti R, Wilkinson M. Safety and effectiveness of intranasal midazolam and fentanyl used in combination in the pediatric emergency department. Am J Emerg Med. 2019 Feb;37(2):237-240. doi: 10.1016/j.ajem.2018.05.036. Epub 2018 May 17.</citation>
    <PMID>30146398</PMID>
  </reference>
  <reference>
    <citation>Kain ZN, Mayes LC, Cicchetti DV, Bagnall AL, Finley JD, Hofstadter MB. The Yale Preoperative Anxiety Scale: how does it compare with a &quot;gold standard&quot;? Anesth Analg. 1997 Oct;85(4):783-8.</citation>
    <PMID>9322455</PMID>
  </reference>
  <reference>
    <citation>Kogan A, Katz J, Efrat R, Eidelman LA. Premedication with midazolam in young children: a comparison of four routes of administration. Paediatr Anaesth. 2002 Oct;12(8):685-9.</citation>
    <PMID>12472704</PMID>
  </reference>
  <reference>
    <citation>Neville DN, Hayes KR, Ivan Y, McDowell ER, Pitetti RD. Double-blind Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department. Acad Emerg Med. 2016 Aug;23(8):910-7. doi: 10.1111/acem.12998.</citation>
    <PMID>27129606</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 31, 2021</study_first_submitted>
  <study_first_submitted_qc>February 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>February 6, 2021</last_update_submitted>
  <last_update_submitted_qc>February 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Texas at Austin</investigator_affiliation>
    <investigator_full_name>Brittany DiFabio</investigator_full_name>
    <investigator_title>Pediatric Emergency Medicine Fellow Physician</investigator_title>
  </responsible_party>
  <keyword>Laceration repair</keyword>
  <keyword>Facial laceration</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Midazolam</keyword>
  <keyword>Fentanyl</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
    <mesh_term>Lacerations</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

